Browse Category

Earnings Reports News 30 January 2026

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive shares rose 5.2% to $89.70 Friday after the company beat Q4 profit forecasts and projected 2026 net sales growth of 2% to 6%. A $794 million after-tax impairment charge pushed GAAP results to a quarterly loss. Q4 net sales reached $5.23 billion, with adjusted earnings of 95 cents per share. Demand held steady in Latin America and Europe, while North American volumes stayed flat.
Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products and Chemicals shares rose 6.2% to $271.89 after fiscal Q1 adjusted EPS reached $3.16, beating estimates and topping guidance. Revenue climbed 6% to $3.1 billion. The company held its FY2026 adjusted EPS forecast at $12.85–$13.15 and expects capex near $4 billion. Helium weakness continued to weigh on volumes and pricing, especially in Asia.
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog shares jumped 6.4% to $306.57 after the company posted record quarterly sales of $1.1 billion and raised its 2026 outlook. Bookings reached $2.3 billion, pushing backlog up 30% to $3.3 billion. The company lifted its quarterly dividend 3% to $0.30 per share. Free cash flow turned negative as Moog increased inventory and faced tariff pressures on margins.
SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi Technologies shares fell 8% to $22.48 Friday after volatile trading, as investors reacted to strong Q4 profits and raised 2026 forecasts. The company reported record loan originations of $10.5 billion and a 78% jump in financial services income. SoFi now expects 2026 adjusted net revenue of $4.655 billion and adjusted EBITDA near $1.6 billion. Next earnings report is set for April 28.
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
Brookfield Renewable stock jumps on 2025 results, 5% dividend hike and Google hydro deal

Brookfield Renewable stock jumps on 2025 results, 5% dividend hike and Google hydro deal

Brookfield Renewable Corporation shares rose 6.5% to $41.88 in New York after reporting higher 2025 results and raising its quarterly dividend to $0.392 per share. The company announced a major hydro power deal with Google and added 8,000 megawatts of new capacity. Brookfield also launched a $400 million equity program to fund buybacks. 2025 FFO fell to $628 million from $794 million, citing asset sales and reorganization.
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific shares rose 1.7% to $93.87 Friday afternoon, outpacing a broader market decline. The move comes ahead of the company’s Feb. 4 earnings report and conference call, its first since announcing a $14.5 billion deal to acquire Penumbra. Investors are watching for details on the acquisition’s impact and the 2026 outlook.
Bloom Energy stock price slips again as BE pulls back ahead of Feb. 5 earnings

Bloom Energy stock price slips again as BE pulls back ahead of Feb. 5 earnings

Bloom Energy shares fell 3.4% to $151.18 Friday, extending a volatile slide after Barclays initiated coverage with an equal-weight rating and a price target suggesting a steep drop. The stock swung between $146.60 and $161.59 as traders weighed new analyst reports and data-center power demand. Plug Power, FuelCell Energy, and Ballard Power Systems also declined. Bloom’s quarterly results are due Feb. 5.
1 52 53 54 55 56 337

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Go toTop